Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
about
Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer.Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinomaPhase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus CisDevelopment history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.Predictive value of GADD153, p21 and c-Jun for chemotherapy response in gastric cancer.Adenocarcinoma of the female urethral diverticulum treated by multimodality therapy.
P2860
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@ast
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@en
type
label
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@ast
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@en
prefLabel
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@ast
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@en
P2093
P1433
P1476
Continuous infusion of 5-fluor ...... urrent gastric adenocarcinoma.
@en
P2093
Matsuoka T
Shirasaka T
P356
10.1002/(SICI)1097-0142(19970701)80:1<1::AID-CNCR1>3.3.CO;2-N
P407
P577
1997-07-01T00:00:00Z